OR WAIT null SECS
The COVID-19 pandemic has led to many changes in how pharmaceutical companies develop vaccines.
More technologies and treatments are emerging for COVID-19—along with new variants.
Partnerships formed during the COVID-19 pandemic have provided a platform for change in assay development and transfers.
April 02, 2020
Regulatory emergency planning has been put to the test with the COVID-19 pandemic.
As COVID-19 rapidly spreads, the bio/pharma industry is committing significant efforts to fast track development of therapies.
The companies are entering into a partnership to develop fully human neutralizing antibodies targeting SARS-CoV-2 to prevent or treat COVID-19.
The event, which was originally scheduled for May 11–13, 2020 at the Gaylord Palms Resort and Convention Center in Kissimmee, FL, will be canceled due to concerns regarding the spread of COVID-19.
April 01, 2020
The patent includes the use of fibroblast cells and adjuvants such as peptides and hydroxychloroquine, which fuels the assembly of natural interferon to overpower the virus.
March 31, 2020
The company is currently seeking interest from companies who have the skill and means to rapidly advance BOLD-100 for the treatment of COVID-19.
March 30, 2020
S is now permitted to import human blood/blood products, other bodily fluids, and tissues that may contain novel coronavirus into its Newark, DE, facility.
The measurement device comes with an infrared semiconductor to examine the molecular structure of materials in a wavelength range up to 2,5 µm for factory and lab applications.
The system, which works to miniaturize, integrate, and automate bioanalytical processes, will give JIB students enrolled in the school’s specialist graduate, PhD, and industry training programs the ability to enhance their industry skills via access to Gyrolab systems and ready-to-use kits.
The Lanexo Lab Inventory, Safety, and Compliance Management System is a digital laboratory informatics solution formulated to reduce time in labs and improve data quality and traceability.